Skip to main content
Erschienen in: Clinical and Experimental Nephrology 2/2012

01.04.2012 | Case Report

Extragastrointestinal stromal tumor in a kidney transplant recipient

verfasst von: Haiyan Tu, Qi Li, Jieru Cai, Zhimin Chen, Hao Yang, Hong Jiang, Youying Mao, Zhangfei Shou, Jianghua Chen

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

The occurrence of de novo malignant neoplasms has been shown in post-transplant recipients receiving immunosuppressive treatment. We present a case of a rare extragastrointestinal stromal tumor (EGIST) located in the pelvic cavity of a kidney transplant patient. A 57-year-old female patient was admitted to our department because of non-specific lower abdominal pain 6 months after renal transplantation. An abdominal computed tomography scan showed a 4.5 cm diameter pelvic tumor mass. The tumor was resected en bloc and confirmed as not being connected to the gastrointestinal wall. Microscopically, the tumor consisted of typical spindle cells with 2−3 mitotic figures per 50 high-power fields. Immunohistochemically, the tumor cells were strongly positive for CD117 (c-kit), and negative for CD34, SMA, s-100 protein, and desmin. Genetically, the tumor showed a silent mutation in exon 18 of the PDGFRA gene at codon 824 GTC > GTT (V824V) [rs2228230]. No recurrence was noted 24 months after the operation. This case draws our attention to the importance of considering EGISTs (including GISTs), even though they are extremely uncommon, in the differential diagnosis of mesenchymal neoplasms, especially in transplant patients.
Literatur
1.
Zurück zum Zitat Buell JF, Gross TG, Woodle ES. Malignancy after transplantation. Transplantation. 2005;80:S254–64.PubMedCrossRef Buell JF, Gross TG, Woodle ES. Malignancy after transplantation. Transplantation. 2005;80:S254–64.PubMedCrossRef
2.
Zurück zum Zitat Kobayashi T, Teruya M, Shimizu S, Nishio Y, Ito A, Kobayashi K, et al. Giant extragastrointestinal stromal tumor. Am J Surg. 2004;188:191–2.PubMedCrossRef Kobayashi T, Teruya M, Shimizu S, Nishio Y, Ito A, Kobayashi K, et al. Giant extragastrointestinal stromal tumor. Am J Surg. 2004;188:191–2.PubMedCrossRef
3.
Zurück zum Zitat Su CC, Li CF, Liao YL, Lin CN, Lu JJ. Immunohistochemical and molecular assessment of human herpesvirus type 8 in gastrointestinal tumours. J Clin Pathol. 2005;58:856–9.PubMedCrossRef Su CC, Li CF, Liao YL, Lin CN, Lu JJ. Immunohistochemical and molecular assessment of human herpesvirus type 8 in gastrointestinal tumours. J Clin Pathol. 2005;58:856–9.PubMedCrossRef
4.
Zurück zum Zitat Padula A, Chin NW, Azeez S, Resetkova E, Andriko JA, Miettinen M. Primary gastrointestinal stromal tumor of the esophagus in an HIV-positive patient. Ann Diagn Pathol. 2005;9:49–53.PubMedCrossRef Padula A, Chin NW, Azeez S, Resetkova E, Andriko JA, Miettinen M. Primary gastrointestinal stromal tumor of the esophagus in an HIV-positive patient. Ann Diagn Pathol. 2005;9:49–53.PubMedCrossRef
5.
Zurück zum Zitat Agaimy A, Wunsch PH. Gastrointestinal stromal tumours (GIST) in kidney transplant recipients—a report of two cases. Nephrol Dial Transplant. 2007;22:1489–90.PubMedCrossRef Agaimy A, Wunsch PH. Gastrointestinal stromal tumours (GIST) in kidney transplant recipients—a report of two cases. Nephrol Dial Transplant. 2007;22:1489–90.PubMedCrossRef
6.
Zurück zum Zitat Reith JD, Goldblum JR, Lyles RH, Weiss SW. Extragastrointestinal (soft tissue) stromal tumors: an analysis of 48 cases with emphasis on histologic predictors of outcome. Mod Pathol. 2000;13:577–85.PubMedCrossRef Reith JD, Goldblum JR, Lyles RH, Weiss SW. Extragastrointestinal (soft tissue) stromal tumors: an analysis of 48 cases with emphasis on histologic predictors of outcome. Mod Pathol. 2000;13:577–85.PubMedCrossRef
7.
Zurück zum Zitat Yamamoto H, Oda Y, Kawaguchi K, Nakamura N, Takahira T, Tamiya S, et al. c-kit and PDGFRA mutations in extragastrointestinal stromal tumor (gastrointestinal stromal tumor of the soft tissue). Am J Surg Pathol. 2004;28:479–88.PubMedCrossRef Yamamoto H, Oda Y, Kawaguchi K, Nakamura N, Takahira T, Tamiya S, et al. c-kit and PDGFRA mutations in extragastrointestinal stromal tumor (gastrointestinal stromal tumor of the soft tissue). Am J Surg Pathol. 2004;28:479–88.PubMedCrossRef
8.
Zurück zum Zitat Miettinen M, Monihan JM, Sarlomo-Rikala M, Kovatich AJ, Carr NJ, Emory TS, et al. Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery: clinicopathologic and immunohistochemical study of 26 cases. Am J Surg Pathol. 1999;23:1109–18.PubMedCrossRef Miettinen M, Monihan JM, Sarlomo-Rikala M, Kovatich AJ, Carr NJ, Emory TS, et al. Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery: clinicopathologic and immunohistochemical study of 26 cases. Am J Surg Pathol. 1999;23:1109–18.PubMedCrossRef
9.
Zurück zum Zitat Saidi RF, Sepehr A, Cosimi AB, Hertl M. Gastrointestinal stromal tumor in a liver transplant recipient. Transplantation. 2008;85:1363.PubMedCrossRef Saidi RF, Sepehr A, Cosimi AB, Hertl M. Gastrointestinal stromal tumor in a liver transplant recipient. Transplantation. 2008;85:1363.PubMedCrossRef
10.
Zurück zum Zitat Camargo MA, Boin I, Mainnardi JP, de Lourdes M, Ayrizono S, Coy CS, et al. Extragastrointestinal stromal tumor and liver transplantation: case report and review. Transplant Proc. 2008;40:3781–3.PubMedCrossRef Camargo MA, Boin I, Mainnardi JP, de Lourdes M, Ayrizono S, Coy CS, et al. Extragastrointestinal stromal tumor and liver transplantation: case report and review. Transplant Proc. 2008;40:3781–3.PubMedCrossRef
11.
Zurück zum Zitat Pasku D, Karantanas A, Giannikaki E, Tzardi M, Velivassakis E, Katonis P. Bilateral gluteal metastases from a misdiagnosed intrapelvic gastrointestinal stromal tumor. World J Surg Oncol. 2008;6:139.PubMedCrossRef Pasku D, Karantanas A, Giannikaki E, Tzardi M, Velivassakis E, Katonis P. Bilateral gluteal metastases from a misdiagnosed intrapelvic gastrointestinal stromal tumor. World J Surg Oncol. 2008;6:139.PubMedCrossRef
12.
Zurück zum Zitat Taniguchi M, Nishida T, Hirota S, Isozaki K, Ito T, Nomura T, et al. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors. Cancer Res. 1999;59:4297–300.PubMed Taniguchi M, Nishida T, Hirota S, Isozaki K, Ito T, Nomura T, et al. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors. Cancer Res. 1999;59:4297–300.PubMed
13.
Zurück zum Zitat Lasota J, Dansonka-Mieszkowska A, Sobin LH, Miettinen M. A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential. Lab Invest. 2004;84:874–83.PubMedCrossRef Lasota J, Dansonka-Mieszkowska A, Sobin LH, Miettinen M. A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential. Lab Invest. 2004;84:874–83.PubMedCrossRef
14.
Zurück zum Zitat Kim JH, Boo YJ, Jung CW, Park SS, Kim SJ, Mok YJ, et al. Multiple malignant extragastrointestinal stromal tumors of the greater omentum and results of immunohistochemistry and mutation analysis: a case report. World J Gastroenterol. 2007;13:3392–5.PubMed Kim JH, Boo YJ, Jung CW, Park SS, Kim SJ, Mok YJ, et al. Multiple malignant extragastrointestinal stromal tumors of the greater omentum and results of immunohistochemistry and mutation analysis: a case report. World J Gastroenterol. 2007;13:3392–5.PubMed
15.
Zurück zum Zitat Hirota S, Ohashi A, Nishida T, Isozaki K, Kinoshita K, Shinomura Y, et al. Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors. Gastroenterology. 2003;125:660–7.PubMedCrossRef Hirota S, Ohashi A, Nishida T, Isozaki K, Kinoshita K, Shinomura Y, et al. Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors. Gastroenterology. 2003;125:660–7.PubMedCrossRef
16.
Zurück zum Zitat Rubin BP, Singer S, Tsao C, Duensing A, Lux ML, Ruiz R, et al. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res. 2001;61:8118–21.PubMed Rubin BP, Singer S, Tsao C, Duensing A, Lux ML, Ruiz R, et al. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res. 2001;61:8118–21.PubMed
17.
Zurück zum Zitat Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med. 2002;347:472–80.PubMedCrossRef Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med. 2002;347:472–80.PubMedCrossRef
18.
Zurück zum Zitat Guba M, von Breitenbuch P, Steinbauer M, Koehl G, Flegel S, Hornung M, et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med. 2002;8:128–35.PubMedCrossRef Guba M, von Breitenbuch P, Steinbauer M, Koehl G, Flegel S, Hornung M, et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med. 2002;8:128–35.PubMedCrossRef
19.
Zurück zum Zitat Stallone G, Schena A, Infante B, Di Paolo S, Loverre A, Maggio G, et al. Sirolimus for Kaposi’s sarcoma in renal-transplant recipients. N Engl J Med. 2005;352:1317–23.PubMedCrossRef Stallone G, Schena A, Infante B, Di Paolo S, Loverre A, Maggio G, et al. Sirolimus for Kaposi’s sarcoma in renal-transplant recipients. N Engl J Med. 2005;352:1317–23.PubMedCrossRef
Metadaten
Titel
Extragastrointestinal stromal tumor in a kidney transplant recipient
verfasst von
Haiyan Tu
Qi Li
Jieru Cai
Zhimin Chen
Hao Yang
Hong Jiang
Youying Mao
Zhangfei Shou
Jianghua Chen
Publikationsdatum
01.04.2012
Verlag
Springer Japan
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 2/2012
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-011-0550-x

Weitere Artikel der Ausgabe 2/2012

Clinical and Experimental Nephrology 2/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.